CEO Sells $1.2M in Shares Following Option Exercise and RSU Settlement
KEQU is trading near its 52-week low of $33.273 (7.9% above the low) on light trading volume (0.1× avg).
Summary
Kewaunee Scientific's CEO sold over $1.2 million in shares, representing more than 1% of the company's market cap, through a disposition to the issuer and tax withholding after exercising options and settling RSUs.
Key Events · Ownership and Investor Activity · KEQU
-
CEO Disposes of Shares
Thomas David Hull III, President & CEO, disposed of 17,000 shares to the issuer for $616,250 and 16,243 shares for tax withholding totaling $588,809.
-
Significant Insider Sale
The total value of shares disposed by the CEO is $1,205,059, which represents over 1% of the company's market capitalization.
-
Post-Exercise Transactions
These dispositions occurred on June 30, 2026, following the exercise of options and settlement of Restricted Stock Units (RSUs).
-
Reduction in Direct Holdings
The CEO's direct holdings decreased from 125,019 shares to 87,388 shares after these transactions.
Analysis · KEQU · Industrial Applications And Services
Kewaunee Scientific's CEO, Thomas David Hull III, disposed of over $1.2 million worth of shares through a disposition to the issuer and tax withholding, following the exercise of options and settlement of Restricted Stock Units (RSUs). This significant sale, representing over 1% of the company's market capitalization, indicates a substantial reduction in the CEO's direct holdings and can be interpreted as a negative signal regarding insider conviction, especially after the company recently reported strong fiscal year 2026 sales.
At the time of this filing, KEQU was trading at $35.91 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $103.1M. The 52-week trading range was $33.27 to $60.89. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.